U.S. health department plans to slash 10,000 jobs as RFK Jr. upends agencies

U.S. health department plans to slash 10,000 jobs as RFK Jr. upends agencies


Robert F. Kennedy Jr., US secretary of Health and Human Services (HHS), during a cabinet meeting at the White House in Washington, DC, US, on Monday, March 24, 2025. 

Samuel Corum | Bloomberg | Getty Images

Health and Human Services Secretary Robert F. Kennedy Jr. plans to slash 10,000 full-time employees across different departments, as he works to reshape the nation’s federal health agencies, an HHS spokesman confirmed Thursday.

Those job cuts are in addition to about 10,000 employees who opted to leave HHS since President Donald Trump took office, through voluntary separation offers. The Wall Street Journal earlier reported the cuts.

HHS is a $1.7 trillion agency that oversees vaccines and other medicines, scientific research, public health infrastructure, pandemic preparedness and food and tobacco products. The department also manages government-funded health care for millions of Americans – including seniors, disabled people and lower-income patients who rely on Medicare, Medicaid, and the Affordable Care Act’s markets.

If the department fully implements the job cuts, it will have shed about a quarter a federal health workers, including the voluntary exits, the Journal reported. That would shrink the department’s workforce to 62,000 employees.

HHS will also drop five of its 10 regional offices, but essential health services won’t be affected, according to the Journal.

Before he was confirmed, Kennedy pledged to end what he calls “corporate corruption” at federal health agencies and purge staff when he stepped into his role in the Trump administration.

He had said he would clear out “entire departments” at the FDA, saying that workers who stand in the way of approval of several controversial or dubious treatments should prepare to “pack their bags.”

Kennedy, a prominent vaccine skeptic, has already made early moves that could impact immunization policy and further dampen uptake in the U.S. at a time when childhood vaccination rates are falling.

He has said he will review the childhood vaccination schedule and is reportedly preparing to remove and replace members of external committees that advise the government on vaccine approvals and other key public health decisions, among other efforts.

His so-called Make America Healthy Again platform also pledges to end the chronic disease epidemic in children and adults. Kennedy has been vocal about making nutritious food, rather than drugs, central to that goal.

This story is developing. Please check back for updates.



Source

Healthy Returns: FDA may add its strongest safety warning to Covid vaccines. Here’s what to know
Health

Healthy Returns: FDA may add its strongest safety warning to Covid vaccines. Here’s what to know

A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. The Food and Drug Administration may add its strongest safety warning to Covid shots – marking another major shift in vaccine oversight.  It could also expand a […]

Read More
‘The next protein’: Fiber is shaping up to be the latest grocery obsession
Health

‘The next protein’: Fiber is shaping up to be the latest grocery obsession

Workers are suspended on a Pepsi sign on a building outside of Allegiant Stadium ahead of LVIII in Las Vegas, Nevada, U.S., February 9, 2024. Brian Snyder | Reuters One of this year’s top food trends is facing some tough competition. Protein captivated consumers and food companies in 2025, but fiber is increasingly stealing the […]

Read More
Danish weight loss drug maker outlines ambitious 2030 strategy, ramping up pressure on Novo, Lilly
Health

Danish weight loss drug maker outlines ambitious 2030 strategy, ramping up pressure on Novo, Lilly

Celsopupo | Istock | Getty Images Zealand Pharma on Thursday outlined an ambitious five-year strategy for its anti-obesity portfolio Thursday, spotlighting how growing competition from smaller players is tightening the race for market leaders Novo Nordisk and Eli Lilly as more of these medicines near market entry. The new strategy, “Metabolic Frontier 2030,” comes as Zealand […]

Read More